NMPA Approval

Levothyroxine Sodium Tablets

Approval Number

国药准字HJ20160235

Registration Date

December 1, 2020

Previous Approval Numbers

H20160235

Drug Information

Generic Name

左甲状腺素钠片

Trade Name

雷替斯

Brand Name

优甲乐

Dosage Form

片剂

Strength

50μg

Drug Type

化学药品

Registration Date

December 1, 2020

Expiry Date

November 30, 2025

Company Address

Glienicker Weg 125，D-12489，Berlin ,Germany

Company Address

Tempelhofer Weg 83, D-12347 Berlin, Germany

Empowering clinical research with data-driven insights and AI-powered tools.

左甲状腺素钠片 - NMPA 批准文号 | MedPath